SBIR/STTR Research Award

Treatment for anemia in companion animals

Award identifier 4b14274b123fa4c3f0162fc55bbe2c7b0a2dec6e317b81dbfb56cc7008b6267fAwarding agency Department of Health and Human Services · Food and Drug Administration

Award amount

$150,000

Program and phase

SBIR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Food and Drug Administration
Recipient company
Companion Sciences, Inc.
Proposal award date
2017-04-01
Contract end date
2018-03-31
UEI
WLXPDLBEXG97
Solicitation number
PA15-269
Topic code
FDA

Research abstract

DESCRIPTION provided by applicant Anemia caused by chronic kidney disease CKD affects approximately million cats and dogs in the United States each year Current treatment options involve the use of medicines designed for humans These medications are not FDA approved for use in cats and dogs but in the absence of other treatment options they are used off label Use of human anemia drugs in animals runs the risk of triggering a severe autoimmune reaction that puts the animalandapos s health at great risk Our intent is to develop a safe medication to treat anemia in companion animals This medication will be a novel synthetic peptide that treats anemia while not triggering the often fatal autoimmune reaction that is caused by repeated use of human anemia drugs The estimated pet population in the U S is M owned cats and M dogs according to the American Pet Products Association The Banfield State of Pet Health study indicates that of cats have CKD Approximately of cats will develop anemia as their renal disease worsens CKD is more common in cats but cancer another major cause of anemia is common in dogs We estimate that approximately cats and dogs would receive treatment with this drug each year In addition to commercialization potential the proposed study can provide information on synthetic anemia drugs which can impact human health The global One Health initiative a consortium of medical societies government agencies and doctors recognizes that human health including mental health through human animal bond animal health and the ecosystem are inexorably linked Insight from this study could lead to a new class of synthetic anemia drugs for humans Our ongoing experiments have identified peptides that bind to the feline and canine receptors responsible for stimulating production of red blood cells We propose to make these peptides in a form that should activate these receptors and then test them in cultured cells we will construct using the feline and canine receptors This will allow us to pick the best peptides as candidates for our new drug This work will set the stage for testing of the drug candidates in cats and dogs to demonstrate their ability to treat anemia PUBLIC HEALTH RELEVANCE A treatment for anemia in companion animals could impact the health of nearly a half million cats and dogs per year Studies funded by NIH and CDC have identified a link between pet ownership and the physical and mental health of humans Sixty two percent of households have pets and the majority of pet owners consider pets as part of the family The one health initiative demonstrates that human and pet health are inexorably linked

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.